Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Unknown × Transplantation Conditioning × Clear all

Phase

Status

Completed 2 Withdrawn 1 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1

Interventions

Cisplatin 245 Carboplatin 174 Oxaliplatin 165 Capecitabine 162 Docetaxel 158 apatinib 154 Paclitaxel 146 Gemcitabine 139 Bevacizumab 137 Radiotherapy 133 camrelizumab 129 Fluorouracil 129 Cyclophosphamide 117 Irinotecan 111 Drug Therapy 94 Etoposide 92 sintilimab 90 S 1 (combination) 78 Leucovorin 74 anlotinib 72 Doxorubicin 71 pembrolizumab 69 tislelizumab 67 Pemetrexed 67 toripalimab 66 Rituximab 62 Dexamethasone 62 Neoadjuvant Therapy 59 Cetuximab 59 Trastuzumab 57

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00946374 2009-07-27

HD-MCL2003

Heidelberg University

Phase 2 Unknown

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡